| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | internal peptidyl-lysine acetylation | 1.84e-05 | 12 | 92 | 3 | GO:0018393 | |
| GeneOntologyBiologicalProcess | lymphoid lineage cell migration into thymus | 1.97e-05 | 2 | 92 | 2 | GO:0097535 | |
| GeneOntologyBiologicalProcess | internal protein amino acid acetylation | 3.76e-05 | 15 | 92 | 3 | GO:0006475 | |
| GeneOntologyBiologicalProcess | lymphoid lineage cell migration | 1.17e-04 | 4 | 92 | 2 | GO:0097534 | |
| GeneOntologyBiologicalProcess | alpha-tubulin acetylation | 1.17e-04 | 4 | 92 | 2 | GO:0071929 | |
| HumanPheno | Abnormally low T cell receptor excision circle level | 1.67e-05 | 9 | 31 | 3 | HP:0031545 | |
| Domain | SH3_domain | 1.26e-06 | 220 | 91 | 9 | IPR001452 | |
| Domain | SH3 | 1.05e-05 | 216 | 91 | 8 | SM00326 | |
| Domain | SH3 | 1.05e-05 | 216 | 91 | 8 | PS50002 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 6.54e-04 | 35 | 91 | 3 | IPR002464 | |
| Domain | SH3_2 | 8.26e-04 | 86 | 91 | 4 | IPR011511 | |
| Domain | SH3_2 | 8.26e-04 | 86 | 91 | 4 | PF07653 | |
| Domain | DEAH_ATP_HELICASE | 8.34e-04 | 38 | 91 | 3 | PS00690 | |
| Domain | TTL | 1.77e-03 | 13 | 91 | 2 | PS51221 | |
| Domain | TTL/TTLL_fam | 1.77e-03 | 13 | 91 | 2 | IPR004344 | |
| Domain | TTL | 1.77e-03 | 13 | 91 | 2 | PF03133 | |
| Domain | WH2 | 2.06e-03 | 14 | 91 | 2 | SM00246 | |
| Domain | SAM/pointed | 2.57e-03 | 117 | 91 | 4 | IPR013761 | |
| Domain | WH2 | 2.70e-03 | 16 | 91 | 2 | PF02205 | |
| Domain | WH2_dom | 4.64e-03 | 21 | 91 | 2 | IPR003124 | |
| Domain | 7tm_3 | 5.09e-03 | 22 | 91 | 2 | PF00003 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 5.09e-03 | 22 | 91 | 2 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 5.09e-03 | 22 | 91 | 2 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 5.09e-03 | 22 | 91 | 2 | PS00979 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 5.09e-03 | 22 | 91 | 2 | PS50259 | |
| Domain | GPCR_3_C | 5.09e-03 | 22 | 91 | 2 | IPR017978 | |
| Domain | PH | 5.25e-03 | 229 | 91 | 5 | PF00169 | |
| Domain | RRM_dom_euk | 5.56e-03 | 23 | 91 | 2 | IPR003954 | |
| Domain | RRM_1 | 5.56e-03 | 23 | 91 | 2 | SM00361 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HIVEP3 GAS2L1 B4GALNT4 SCAP ZNF48 EPOP SH2B3 NBEAL2 CASKIN1 KSR2 INTS1 PER1 ANKRD34A SAC3D1 FBXL19 MBD6 DYSF ADGRA2 TJP3 | 1.65e-10 | 1105 | 96 | 19 | 35748872 |
| Pubmed | 7.33e-09 | 25 | 96 | 5 | 12029088 | ||
| Pubmed | HIVEP3 KRBA1 ASAP2 SCAP RTEL1 PPFIBP1 ADAMTS16 PER1 ARHGEF18 IRF2BPL MAST3 | 1.24e-07 | 493 | 96 | 11 | 15368895 | |
| Pubmed | 4.35e-07 | 103 | 96 | 6 | 21706016 | ||
| Pubmed | 5.55e-07 | 24 | 96 | 4 | 25176648 | ||
| Pubmed | Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS. | 5.76e-07 | 108 | 96 | 6 | 19531213 | |
| Pubmed | 1.62e-06 | 31 | 96 | 4 | 24014668 | ||
| Pubmed | 3.16e-06 | 225 | 96 | 7 | 12168954 | ||
| Pubmed | 3.79e-06 | 329 | 96 | 8 | 17474147 | ||
| Pubmed | 7.26e-06 | 14 | 96 | 3 | 36302841 | ||
| Pubmed | Genetic evidence that relative synaptic efficacy biases the outcome of synaptic competition. | 7.54e-06 | 2 | 96 | 2 | 12879071 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 32750380 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 27009365 | ||
| Pubmed | BAT2 and BAT3 polymorphisms as novel genetic risk factors for rejection after HLA-related SCT. | 7.54e-06 | 2 | 96 | 2 | 25111513 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 2156268 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 24034616 | ||
| Pubmed | BCL11B KCNA3 PELP1 CASKIN1 KSR2 DNM3 ARHGEF18 SIPA1 GRM1 PRRC2A SHISA7 RCOR2 | 1.40e-05 | 963 | 96 | 12 | 28671696 | |
| Pubmed | 1.91e-05 | 19 | 96 | 3 | 21666133 | ||
| Pubmed | 2.25e-05 | 20 | 96 | 3 | 16221724 | ||
| Pubmed | Neurog1 and Neurog2 control two waves of neuronal differentiation in the piriform cortex. | 2.25e-05 | 20 | 96 | 3 | 24403153 | |
| Pubmed | C-Boutons and Their Influence on Amyotrophic Lateral Sclerosis Disease Progression. | 2.26e-05 | 3 | 96 | 2 | 34380764 | |
| Pubmed | Evidence for a single heptahelical domain being turned on upon activation of a dimeric GPCR. | 2.26e-05 | 3 | 96 | 2 | 15660124 | |
| Pubmed | PRAM-1 is required for optimal integrin-dependent neutrophil function. | 2.26e-05 | 3 | 96 | 2 | 15572693 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 20626023 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 27568555 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 19401562 | ||
| Pubmed | Temporal requirement for hedgehog signaling in ventral telencephalic patterning. | 2.61e-05 | 21 | 96 | 3 | 15371303 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 2.63e-05 | 430 | 96 | 8 | 35044719 | |
| Pubmed | 3.02e-05 | 22 | 96 | 3 | 19820705 | ||
| Pubmed | Helios expression coordinates the development of a subset of striatopallidal medium spiny neurons. | 3.47e-05 | 23 | 96 | 3 | 28289129 | |
| Pubmed | Overlapping role of dynamin isoforms in synaptic vesicle endocytosis. | 4.51e-05 | 4 | 96 | 2 | 21689597 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 31036156 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 20404100 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 27462817 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 30355159 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 12149250 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 11301322 | ||
| Pubmed | Ofd1 controls dorso-ventral patterning and axoneme elongation during embryonic brain development. | 5.06e-05 | 26 | 96 | 3 | 23300826 | |
| Pubmed | Chd2 Is Necessary for Neural Circuit Development and Long-Term Memory. | 5.68e-05 | 27 | 96 | 3 | 30344048 | |
| Pubmed | Lateral Thalamic Eminence: A Novel Origin for mGluR1/Lot Cells. | 6.35e-05 | 28 | 96 | 3 | 27178193 | |
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 18182848 | ||
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 22966049 | ||
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 30058223 | ||
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 20971735 | ||
| Pubmed | Distinct Notch1 and BCL11B requirements mediate human γδ/αβ T cell development. | 7.50e-05 | 5 | 96 | 2 | 32255245 | |
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 9223334 | ||
| Pubmed | A versatile viral toolkit for functional discovery in the nervous system. | 7.50e-05 | 5 | 96 | 2 | 35784651 | |
| Pubmed | 7.72e-05 | 157 | 96 | 5 | 30186101 | ||
| Pubmed | 1.12e-04 | 6 | 96 | 2 | 37949368 | ||
| Pubmed | 1.12e-04 | 6 | 96 | 2 | 34552196 | ||
| Pubmed | HiQuant: Rapid Postquantification Analysis of Large-Scale MS-Generated Proteomics Data. | 1.12e-04 | 6 | 96 | 2 | 27086506 | |
| Pubmed | 1.12e-04 | 6 | 96 | 2 | 18786926 | ||
| Pubmed | 1.12e-04 | 6 | 96 | 2 | 33863785 | ||
| Pubmed | 1.12e-04 | 6 | 96 | 2 | 2813433 | ||
| Pubmed | 1.12e-04 | 6 | 96 | 2 | 9808459 | ||
| Pubmed | 1.15e-04 | 34 | 96 | 3 | 20181579 | ||
| Pubmed | 1.15e-04 | 34 | 96 | 3 | 25631876 | ||
| Pubmed | 1.41e-04 | 284 | 96 | 6 | 15057824 | ||
| Pubmed | 1.57e-04 | 7 | 96 | 2 | 9819391 | ||
| Pubmed | 1.57e-04 | 7 | 96 | 2 | 34060591 | ||
| Pubmed | CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery. | 1.57e-04 | 7 | 96 | 2 | 17255943 | |
| Pubmed | MEK drives BRAF activation through allosteric control of KSR proteins. | 1.57e-04 | 7 | 96 | 2 | 29433126 | |
| Pubmed | 1.57e-04 | 7 | 96 | 2 | 9196000 | ||
| Pubmed | Altered forebrain and hindbrain development in mice mutant for the Gsh-2 homeobox gene. | 1.57e-04 | 7 | 96 | 2 | 9398437 | |
| Pubmed | Schnurri-3 regulates ERK downstream of WNT signaling in osteoblasts. | 1.57e-04 | 7 | 96 | 2 | 23945236 | |
| Pubmed | Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities. | 2.09e-04 | 8 | 96 | 2 | 15719014 | |
| Pubmed | The integrated stress response contributes to tRNA synthetase-associated peripheral neuropathy. | 2.09e-04 | 8 | 96 | 2 | 34516839 | |
| Pubmed | 2.09e-04 | 8 | 96 | 2 | 9126384 | ||
| Pubmed | Lhx2 selector activity specifies cortical identity and suppresses hippocampal organizer fate. | 2.09e-04 | 8 | 96 | 2 | 18202285 | |
| Pubmed | PFGE mapping and RFLP analysis of the S/D region of the mouse H-2 complex. | 2.09e-04 | 8 | 96 | 2 | 1351875 | |
| Pubmed | 2.09e-04 | 8 | 96 | 2 | 28916788 | ||
| Pubmed | 2.16e-04 | 42 | 96 | 3 | 26166575 | ||
| Pubmed | Respiratory Network Stability and Modulatory Response to Substance P Require Nalcn. | 2.68e-04 | 9 | 96 | 2 | 28392070 | |
| Pubmed | 2.68e-04 | 9 | 96 | 2 | 31396962 | ||
| Pubmed | 3.22e-04 | 48 | 96 | 3 | 24262325 | ||
| Pubmed | Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. | 3.34e-04 | 10 | 96 | 2 | 9069281 | |
| Pubmed | Enhanced Abventricular Proliferation Compensates Cell Death in the Embryonic Cerebral Cortex. | 3.34e-04 | 10 | 96 | 2 | 27620979 | |
| Pubmed | Screening for premutation in the FMR1 gene in male patients suspected of spinocerebellar ataxia. | 3.34e-04 | 10 | 96 | 2 | 19235102 | |
| Pubmed | 3.34e-04 | 10 | 96 | 2 | 29719245 | ||
| Pubmed | 4.07e-04 | 486 | 96 | 7 | 20936779 | ||
| Pubmed | 4.08e-04 | 11 | 96 | 2 | 22315402 | ||
| Pubmed | Mouse Rab23 regulates hedgehog signaling from smoothened to Gli proteins. | 4.08e-04 | 11 | 96 | 2 | 16364285 | |
| Pubmed | 4.08e-04 | 11 | 96 | 2 | 21289201 | ||
| Pubmed | 4.08e-04 | 11 | 96 | 2 | 31816041 | ||
| Pubmed | Deregulation of ZPR1 causes respiratory failure in spinal muscular atrophy. | 4.08e-04 | 11 | 96 | 2 | 28811488 | |
| Pubmed | 4.08e-04 | 11 | 96 | 2 | 11748145 | ||
| Pubmed | 4.12e-04 | 347 | 96 | 6 | 17114649 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 4.63e-04 | 231 | 96 | 5 | 16452087 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 4.65e-04 | 497 | 96 | 7 | 36774506 | |
| Pubmed | Developmental origin of the neuronal subtypes that comprise the amygdalar fear circuit in the mouse. | 4.89e-04 | 12 | 96 | 2 | 20484636 | |
| Pubmed | 4.89e-04 | 12 | 96 | 2 | 7993390 | ||
| Pubmed | TMED2 binding restricts SMO to the ER and Golgi compartments. | 4.89e-04 | 12 | 96 | 2 | 35353806 | |
| Pubmed | 4.89e-04 | 12 | 96 | 2 | 38367882 | ||
| Pubmed | Fine mapping of the MHC Class III region demonstrates association of AIF1 and rheumatoid arthritis. | 4.89e-04 | 12 | 96 | 2 | 18835879 | |
| Pubmed | 4.89e-04 | 12 | 96 | 2 | 35192416 | ||
| Pubmed | 5.08e-04 | 56 | 96 | 3 | 34170322 | ||
| Pubmed | 5.35e-04 | 57 | 96 | 3 | 21368052 | ||
| Pubmed | 5.77e-04 | 13 | 96 | 2 | 27633995 | ||
| Pubmed | 5.77e-04 | 13 | 96 | 2 | 20159447 | ||
| Pubmed | A targeted multienzyme mechanism for selective microtubule polyglutamylation. | 5.77e-04 | 13 | 96 | 2 | 17499049 | |
| Interaction | NCK2 interactions | ASAP2 KCNA3 ATN1 WIPF1 EFS GGN CCDC120 CBARP FBXL19 MBD6 LCP2 WIPF2 PRRC2A ASAP1 | 1.65e-11 | 262 | 93 | 14 | int:NCK2 |
| Interaction | TOP3B interactions | HIVEP3 GAS2L1 B4GALNT4 SCAP ZNF48 SMG7 EPOP PELP1 SH2B3 RTEL1 NBEAL2 CASKIN1 KSR2 INTS1 PER1 ANKRD34A SAC3D1 FBXL19 MBD6 DYSF ADGRA2 PRRC2A TJP3 | 1.55e-07 | 1470 | 93 | 23 | int:TOP3B |
| Interaction | SH3RF1 interactions | 6.77e-07 | 108 | 93 | 7 | int:SH3RF1 | |
| Interaction | NCK1 interactions | 1.73e-05 | 244 | 93 | 8 | int:NCK1 | |
| Interaction | RIPOR2 interactions | 4.16e-05 | 15 | 93 | 3 | int:RIPOR2 | |
| Interaction | YWHAE interactions | KCNA3 SH2B3 PPFIBP1 PIK3R2 ZPR1 KSR2 MEPCE ANKRD34A CBARP MBD6 ATAT1 LCP2 MAP2K2 PRRC2A CNOT4 WDR62 MAST3 | 5.48e-05 | 1256 | 93 | 17 | int:YWHAE |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | PRAM1 PIK3R2 TGFBR3L ARHGEF18 CBARP MAP2K2 ZNF414 MAST3 KLF2 TJP3 | 6.92e-06 | 797 | 96 | 10 | chr19p13 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 8.08e-04 | 206 | 64 | 5 | 682 | |
| GeneFamily | Tubulin tyrosine ligase family | 1.09e-03 | 14 | 64 | 2 | 779 | |
| GeneFamily | DNA helicases | 1.62e-03 | 17 | 64 | 2 | 1167 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 1.62e-03 | 17 | 64 | 2 | 1291 | |
| Coexpression | GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_DN | 9.10e-06 | 200 | 96 | 7 | M7441 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-07 | 180 | 96 | 7 | ca2a35bfb67347e47f511589a3d0f763e6664634 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-07 | 180 | 96 | 7 | 4e9e8cde2919610c4ac0025b1c9819808048bc1d | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-07 | 180 | 96 | 7 | 466381bf93c3da6a2a241daadb68e9aad2964eae | |
| ToppCell | NS-critical-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.28e-06 | 176 | 96 | 6 | 7cf1a06ceee1ec06532f44c729c31b4d58e5ea49 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.43e-06 | 178 | 96 | 6 | 9e1f2596fcea5b79cc50b58d83706bb8605e224f | |
| ToppCell | PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.43e-06 | 178 | 96 | 6 | aa659bd283c4dfbe292cd8698bbf6b1999ca3314 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.43e-06 | 178 | 96 | 6 | bf1d273802a4f42e52ea1bd2a0cae2039559c093 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-06 | 193 | 96 | 6 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-06 | 193 | 96 | 6 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-06 | 193 | 96 | 6 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.24e-06 | 196 | 96 | 6 | 01cea0bb0b938d0986fd2ddae06597b8af1768ee | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-06 | 197 | 96 | 6 | c10dd1aaec01fb662eac83dfde90e3e426665d65 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-06 | 197 | 96 | 6 | 2844dbcd0a673ed81c99920aa45858651a00736d | |
| ToppCell | Caecum-(5)_Dendritic_cell-(51)_cDC1|Caecum / shred on region, Cell_type, and subtype | 4.62e-06 | 199 | 96 | 6 | 2b97fda45241b2ce7be904cf081cabcf3eb5ba1d | |
| ToppCell | Caecum-Dendritic_cell-cDC1|Caecum / Region, Cell class and subclass | 4.62e-06 | 199 | 96 | 6 | 9ab38a0060a883de6fe3da8cdac42e124d7981d9 | |
| ToppCell | Transverse-(5)_Dendritic_cell-(50)_cDC2|Transverse / shred on region, Cell_type, and subtype | 4.76e-06 | 200 | 96 | 6 | eea523f7512b54d7443651bce3ff6d043a9897aa | |
| ToppCell | Transverse-Dendritic_cell-cDC2|Transverse / Region, Cell class and subclass | 4.76e-06 | 200 | 96 | 6 | 80730a6372627543b84d8fb1b94c481db17c6500 | |
| ToppCell | (51)_cDC1|World / shred on Cell_type and subtype | 5.33e-06 | 204 | 96 | 6 | a8cf4180c406674b7541917d1fc6127686ba5f8a | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.44e-05 | 159 | 96 | 5 | a5fee9e7ee00c20a4ba30b0dfaf1189fb109a1af | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Lymphocytic-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-05 | 165 | 96 | 5 | 475905d608fac628960188ae4a18010b8097417e | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Spindle_Cell-1|TCGA-Uvea / Sample_Type by Project: Shred V9 | 3.18e-05 | 168 | 96 | 5 | b427746929bb40e3d1b5f1c40d302b792d6b32a5 | |
| ToppCell | Monocytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.36e-05 | 170 | 96 | 5 | 4e93b66b3033e6e4d5f6d2f41974623a53108f5e | |
| ToppCell | facs-MAT-Fat-18m-Lymphocytic-T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-05 | 173 | 96 | 5 | 97391a763c17ce0107c9e2386e88c417ac75a72e | |
| ToppCell | facs-SCAT-Fat-18m-Lymphocytic-NK_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.07e-05 | 177 | 96 | 5 | be35bb178fbc149f8a12984c012d98b486325ba9 | |
| ToppCell | droplet-Fat-SCAT-30m-Lymphocytic-T_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.07e-05 | 177 | 96 | 5 | baf78a8dad55f124f56585f88b10b58c0269680f | |
| ToppCell | PND14-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.19e-05 | 178 | 96 | 5 | 63f5880a5b514e20ef2c07a6a9cb8df34e6cede5 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.19e-05 | 178 | 96 | 5 | 82c84f8b8a7e6a3d3be3351b348a37143279c100 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-05 | 178 | 96 | 5 | a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-05 | 178 | 96 | 5 | 1bddbc083c36657bd6910f7466126ab325e88176 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.19e-05 | 178 | 96 | 5 | cb91558469ae0748106fb0b6d702edb0ff21a884 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD141+_DCs|normal_Lymph_Node / Location, Cell class and cell subclass | 4.30e-05 | 179 | 96 | 5 | ec995ccd6e1dbd06287ad836c232d9aed1cf94a8 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-05 | 179 | 96 | 5 | a3922476f33d2e4137a12dbda21a1703dff79684 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.30e-05 | 179 | 96 | 5 | 6bbb32d7e582a96cb3cfc3eb911b05d518e7d5e9 | |
| ToppCell | CTRL-Myeloid-cDC|Myeloid / Disease state, Lineage and Cell class | 4.65e-05 | 182 | 96 | 5 | ee137574b8f0e684a4a7cb26226877c471cae433 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.65e-05 | 182 | 96 | 5 | 14a117c5e50db31ee1b2cf4df4d133451fd6d55f | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Dendritic-DC1|lymph-node_spleen / Manually curated celltypes from each tissue | 4.77e-05 | 183 | 96 | 5 | c9e3d91f4c3395a73295b92e25608e0effb5d241 | |
| ToppCell | CTRL-Myeloid-cDC|CTRL / Disease state, Lineage and Cell class | 4.77e-05 | 183 | 96 | 5 | 20c4d16de7e090df3556a4458f783383a26871b6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-CD45____T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-05 | 184 | 96 | 5 | 2c8e9ddce3e60302965dcf9dee77c4fe33e4071d | |
| ToppCell | droplet-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-05 | 185 | 96 | 5 | 6a85399cfdb9b89683c874e7f046957f9a601dc2 | |
| ToppCell | droplet-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-05 | 185 | 96 | 5 | 64791056cdbb739136dbef08f4b16e2b5427faad | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.16e-05 | 186 | 96 | 5 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic-DC1|Liver / Manually curated celltypes from each tissue | 5.16e-05 | 186 | 96 | 5 | e823529ffd06352c6bdec102f221fdf27f7c7369 | |
| ToppCell | Cerebellum-Neuronal|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.29e-05 | 187 | 96 | 5 | 61b9d6eb131a674598aa8409d7fa909c8765442d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.29e-05 | 187 | 96 | 5 | 3d4e81183cb7f6522ae654ddac494662402aa86d | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma|TCGA-Kidney / Sample_Type by Project: Shred V9 | 5.43e-05 | 188 | 96 | 5 | e711c7a46d7cfa030ca2982eacc1dae5af5788dd | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.85e-05 | 191 | 96 | 5 | 7edc22e7e70697fb22690699efb352577162709b | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.14e-05 | 193 | 96 | 5 | e1855cff9a6bcfda9188b9fdf6c9d698405da990 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.30e-05 | 194 | 96 | 5 | 216cba1a04b1a24b080322bc950e7fa2dade5ff1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-05 | 195 | 96 | 5 | 23ced69fd904f1d4114b1a7f99f4b5f65ea8824b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 196 | 96 | 5 | 7cbb19108b4553ef60ef5c230a29de1662c02efe | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 196 | 96 | 5 | 4cd1e6b7a791e11a40b19f971b7011bd11fe6273 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 196 | 96 | 5 | adee900dcd16dbaba15c58bdcace09ba20214950 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC1-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.93e-05 | 198 | 96 | 5 | e1df453729ec565f1a55a6c649e87aa9e0c5cacf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.93e-05 | 198 | 96 | 5 | 07701c73137947ed4a27e225975329235bbb8734 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.93e-05 | 198 | 96 | 5 | 31ba87552be97c9b78c9e82f98e96699ccb19824 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.93e-05 | 198 | 96 | 5 | 1378c6d4ceb84b42fdd6556be3296df7a8059e6e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.93e-05 | 198 | 96 | 5 | 92416e65a0dc1a4bf931833407620ea05d362f56 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC1|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.93e-05 | 198 | 96 | 5 | 2cfdcbf33854f314c41ea0f01c31bc27b66c2f91 | |
| ToppCell | Adult-Immune|Adult / Lineage, Cell type, age group and donor | 6.93e-05 | 198 | 96 | 5 | 9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.93e-05 | 198 | 96 | 5 | 440af8f90c7afa1c07000806bcf9110b70f489fb | |
| ToppCell | Transverse-(5)_Dendritic_cell-(51)_cDC1|Transverse / shred on region, Cell_type, and subtype | 7.10e-05 | 199 | 96 | 5 | 52dd1c4cd372f8ee515307a9200e357bb2145888 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC1|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.10e-05 | 199 | 96 | 5 | c6da5c517dbcfa621fa6dda9e0c1985ba2f3bbdb | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC1-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.10e-05 | 199 | 96 | 5 | b9613e88c4b752529d6ae20857744418207b0830 | |
| ToppCell | Caecum-(5)_Dendritic_cell-(50)_cDC2|Caecum / shred on region, Cell_type, and subtype | 7.10e-05 | 199 | 96 | 5 | bf8a10a9db7e8e0a6e2b53747949f442fe0e581e | |
| ToppCell | Caecum-Dendritic_cell-cDC2|Caecum / Region, Cell class and subclass | 7.10e-05 | 199 | 96 | 5 | 944c567307082dd54dc141e93965d46f4ec8bc1f | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.10e-05 | 199 | 96 | 5 | 14e09eaa2335d4503de50250eb4258dd5b85b304 | |
| ToppCell | Transverse-Dendritic_cell-cDC1|Transverse / Region, Cell class and subclass | 7.10e-05 | 199 | 96 | 5 | b68419939d206417158a703f60a374bf8ec5d5a1 | |
| ToppCell | Kidney-Endothelial|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients. | 7.10e-05 | 199 | 96 | 5 | b543f0686522df43737e9ffa5c9733e42b8a9f4d | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 7.27e-05 | 200 | 96 | 5 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | (50)_cDC2|World / shred on Cell_type and subtype | 8.36e-05 | 206 | 96 | 5 | d519adeb8290fcce107e81a439ba3bf1e231b55b | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial-Lgr5+_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-04 | 139 | 96 | 4 | c300f953ff9c5e820ff16bcd9942d279b37b79db | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-04 | 139 | 96 | 4 | 95b19d7459d9b54162cf01d278462245d34802d5 | |
| ToppCell | LPS-antiTNF-Endothelial-Epi-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.66e-04 | 144 | 96 | 4 | 75b16adfbe84f69376e6566d531ba7919d5c5192 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Neuroendocrine_Carcinoma-2|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.80e-04 | 146 | 96 | 4 | bc2adef529d0bbfcccef7435401a47a6ffcc1832 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Neuroendocrine_Carcinoma|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.80e-04 | 146 | 96 | 4 | 72c1e7e0c2b6ff6c4084af61fa19c2b8eab16eda | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 157 | 96 | 4 | a9e077f686382303f0437ebfa4f11d273ba9fe40 | |
| ToppCell | LPS-antiTNF-Endothelial-Epi-like-Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.69e-04 | 157 | 96 | 4 | abfd05ed993b80822739f47a735f154092a23632 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.87e-04 | 159 | 96 | 4 | 2f6c60ddff2208a68146f9786143d9aefd528840 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.87e-04 | 159 | 96 | 4 | ded4e3626a62fb6334403b7213b467fb7e8131c3 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.97e-04 | 160 | 96 | 4 | 5d8d97c3da5837ba5fe743d2f8438f5cb7cea64b | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT-T-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.97e-04 | 160 | 96 | 4 | 5c931e859acf67c1c8664941e0e44d195f8ba75b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.16e-04 | 162 | 96 | 4 | 9dca585c734faea0e1122c70f5dc36cef3dbd2c6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.16e-04 | 162 | 96 | 4 | 5428c9fdb816f564395ebb4520448e5f3a42b025 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-D-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.26e-04 | 163 | 96 | 4 | 8d2b2119c6b3d5b677da6f377fd85146590e1246 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-D|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.26e-04 | 163 | 96 | 4 | acfb2ece6202479e615d54fd3ecb8b4a571b5a18 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.56e-04 | 166 | 96 | 4 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 4.56e-04 | 166 | 96 | 4 | 6210a136efb99d70c2026b6454363f1bd2723558 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC1|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.56e-04 | 166 | 96 | 4 | 0590e404f45afce90e20f93f90a3def83949c66b | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.66e-04 | 167 | 96 | 4 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.66e-04 | 167 | 96 | 4 | 774f3264318b002d0df5d06d41d645366038d0bf | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.66e-04 | 167 | 96 | 4 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-04 | 168 | 96 | 4 | e156297a7515e785a9e79a9676700bd3a9d92b98 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.77e-04 | 168 | 96 | 4 | 52fd65024af8683db11d931f7563cbe8eb815d1c | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-04 | 168 | 96 | 4 | 32e0bc0873baa13027241063283ef26d2aab56f5 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-04 | 168 | 96 | 4 | 2e88d9cb7c80a4656fab290db8b45a5a0599d769 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-basal_bladder_epithelial_cell_(Krt5+Krt14+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-04 | 168 | 96 | 4 | ca65321259711321c175ede67bd67a47aad81d7a | |
| ToppCell | Healthy_Control-Lymphoid-pDC|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.88e-04 | 169 | 96 | 4 | a4e9b8b2f0338203455ba941b8f99bf4884d26f0 | |
| ToppCell | facs-Marrow-KLS-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.88e-04 | 169 | 96 | 4 | d6ad3b637de2935c656aad47ad82d6e8a8bd1227 | |
| ToppCell | facs-Marrow-KLS-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.88e-04 | 169 | 96 | 4 | 60ef186518d0dc63dbded2a77c65cfe3129df754 | |
| ToppCell | Healthy_Control-Lymphoid-pDC-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.88e-04 | 169 | 96 | 4 | 338ce99897cb522b86edd603f75bc15ec4dfcda3 | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 1.38e-06 | 193 | 94 | 8 | 3262_UP | |
| Drug | idebenone | 4.52e-06 | 59 | 94 | 5 | CID000003686 | |
| Drug | Alfaxalone [23930-19-0]; Down 200; 12uM; HL60; HT_HG-U133A | 1.66e-05 | 195 | 94 | 7 | 3135_DN | |
| Drug | Decamethonium bromide [541-22-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.71e-05 | 196 | 94 | 7 | 7353_DN | |
| Drug | U-62066 [87151-85-7]; Down 200; 1uM; PC3; HT_HG-U133A | 1.77e-05 | 197 | 94 | 7 | 4553_DN | |
| Drug | Suprofen [40828-46-4]; Down 200; 15.4uM; PC3; HT_HG-U133A | 1.83e-05 | 198 | 94 | 7 | 4005_DN | |
| Drug | Piroxicam [36322-90-4]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.89e-05 | 199 | 94 | 7 | 7445_UP | |
| Drug | Rilmenidine hemifumarate [54187-04-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.46e-04 | 192 | 94 | 6 | 6512_UP | |
| Drug | Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; PC3; HT_HG-U133A | 1.51e-04 | 193 | 94 | 6 | 4241_DN | |
| Drug | Thonzonium bromide [553-08-2]; Up 200; 6.8uM; MCF7; HT_HG-U133A | 1.55e-04 | 194 | 94 | 6 | 6457_UP | |
| Drug | Karakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.55e-04 | 194 | 94 | 6 | 4763_DN | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 10uM; PC3; HT_HG-U133A | 1.55e-04 | 194 | 94 | 6 | 4559_DN | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; PC3; HT_HG-U133A | 1.55e-04 | 194 | 94 | 6 | 4319_DN | |
| Drug | Delcorine; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.59e-04 | 195 | 94 | 6 | 3613_UP | |
| Drug | Hecogenin [467-55-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.59e-04 | 195 | 94 | 6 | 3457_DN | |
| Drug | Alfaxalone [23930-19-0]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.59e-04 | 195 | 94 | 6 | 5451_UP | |
| Drug | Hesperetin [520-33-2]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.64e-04 | 196 | 94 | 6 | 5350_UP | |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; HL60; HT_HG-U133A | 1.64e-04 | 196 | 94 | 6 | 2571_DN | |
| Drug | N-Acetyl-L-leucine [1188-21-2]; Down 200; 23uM; MCF7; HT_HG-U133A | 1.64e-04 | 196 | 94 | 6 | 6462_DN | |
| Drug | Gabazine [105538-73-6]; Down 200; 10.8uM; PC3; HT_HG-U133A | 1.64e-04 | 196 | 94 | 6 | 4236_DN | |
| Drug | PNU-0251126 [267429-19-6]; Up 200; 1uM; PC3; HT_HG-U133A | 1.64e-04 | 196 | 94 | 6 | 3692_UP | |
| Drug | Trimetazidine dihydrochloride [13171-25-0]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.64e-04 | 196 | 94 | 6 | 2876_DN | |
| Drug | PNU-0251126 [267429-19-6]; Up 200; 1uM; MCF7; HT_HG-U133A | 1.64e-04 | 196 | 94 | 6 | 4714_UP | |
| Drug | bromophenol blue | 1.65e-04 | 26 | 94 | 3 | CID000008272 | |
| Drug | Lincomycin hydrochloride [859-18-7]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.68e-04 | 197 | 94 | 6 | 7411_UP | |
| Drug | estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A | 1.68e-04 | 197 | 94 | 6 | 5905_DN | |
| Drug | Enoxacin [74011-58-8]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 1.68e-04 | 197 | 94 | 6 | 5616_DN | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.68e-04 | 197 | 94 | 6 | 5605_DN | |
| Drug | Clemastine fumarate [14976-57-9]; Down 200; 8.6uM; HL60; HT_HG-U133A | 1.68e-04 | 197 | 94 | 6 | 2412_DN | |
| Drug | Adamantamine fumarate [80789-67-9]; Up 200; 9.6uM; PC3; HT_HG-U133A | 1.68e-04 | 197 | 94 | 6 | 4222_UP | |
| Drug | Doxylamine succinate [562-10-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.68e-04 | 197 | 94 | 6 | 1473_DN | |
| Drug | Flucloxacillin sodium [1847-24-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.68e-04 | 197 | 94 | 6 | 5527_DN | |
| Drug | Pimethixene maleate [13187-06-9]; Down 200; 9.8uM; HL60; HT_HG-U133A | 1.68e-04 | 197 | 94 | 6 | 2395_DN | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 1.68e-04 | 197 | 94 | 6 | 1541_DN | |
| Drug | Flutamide [13311-84-7]; Up 200; 14.4uM; PC3; HT_HG-U133A | 1.73e-04 | 198 | 94 | 6 | 3803_UP | |
| Drug | Torsemide [56211-40-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.73e-04 | 198 | 94 | 6 | 5476_DN | |
| Drug | Prednicarbate [73771-04-7]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 1.73e-04 | 198 | 94 | 6 | 3542_DN | |
| Drug | Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; HL60; HT_HG-U133A | 1.73e-04 | 198 | 94 | 6 | 1299_DN | |
| Drug | Verapamyl hydrochloride [152-11-4]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 1.73e-04 | 198 | 94 | 6 | 5387_UP | |
| Drug | Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 1.78e-04 | 199 | 94 | 6 | 1500_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 1.78e-04 | 199 | 94 | 6 | 1488_DN | |
| Drug | Dacarbazine [4342-03-4]; Up 200; 22uM; MCF7; HT_HG-U133A | 1.78e-04 | 199 | 94 | 6 | 6816_UP | |
| Drug | (S)-(-)-Atenolol [93379-54-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 1.78e-04 | 199 | 94 | 6 | 6444_UP | |
| Drug | SC-58125; Up 200; 10uM; MCF7; HG-U133A | 1.78e-04 | 199 | 94 | 6 | 254_UP | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Up 200; 8uM; MCF7; HT_HG-U133A | 1.78e-04 | 199 | 94 | 6 | 3273_UP | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 1.78e-04 | 199 | 94 | 6 | 2310_DN | |
| Drug | wortmannin from Penicillium funiculosum; Down 200; 0.01uM; MCF7; HT_HG-U133A | 1.83e-04 | 200 | 94 | 6 | 7002_DN | |
| Drug | Carbenoxolone disodium salt [7421-40-1]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 1.83e-04 | 200 | 94 | 6 | 4173_UP | |
| Disease | chronic myeloid leukemia (implicated_via_orthology) | 9.15e-05 | 5 | 90 | 2 | DOID:8552 (implicated_via_orthology) | |
| Disease | eosinophil count | HIVEP3 LINC02881 PELP1 SH2B3 PIK3R2 ZPR1 ARHGEF18 LCP2 DYSF MAP2K2 WIPF2 GABBR1 MAST3 KLF2 | 1.60e-04 | 1488 | 90 | 14 | EFO_0004842 |
| Disease | primary immunodeficiency disease (is_implicated_in) | 2.89e-04 | 42 | 90 | 3 | DOID:612 (is_implicated_in) | |
| Disease | response to high fat food intake, triglyceride change measurement | 3.27e-04 | 9 | 90 | 2 | EFO_0007681, EFO_0007684 | |
| Disease | eosinophil percentage of leukocytes | 4.58e-04 | 746 | 90 | 9 | EFO_0007991 | |
| Disease | platelet component distribution width | 4.99e-04 | 755 | 90 | 9 | EFO_0007984 | |
| Disease | cathepsin L1 measurement | 1.07e-03 | 16 | 90 | 2 | EFO_0010619 | |
| Disease | Familial Progressive Myoclonic Epilepsy | 1.21e-03 | 17 | 90 | 2 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 1.21e-03 | 17 | 90 | 2 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 1.21e-03 | 17 | 90 | 2 | C0751778 | |
| Disease | Biotin-Responsive Encephalopathy | 1.21e-03 | 17 | 90 | 2 | C0751780 | |
| Disease | May-White Syndrome | 1.21e-03 | 17 | 90 | 2 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 1.21e-03 | 17 | 90 | 2 | C0751781 | |
| Disease | Action Myoclonus-Renal Failure Syndrome | 1.36e-03 | 18 | 90 | 2 | C0751779 | |
| Disease | cortical surface area measurement | BCL11B LINC02881 EPOP EFS PPFIBP1 MBD6 HS3ST3B1 DYSF ADGRA2 PRRC2A CNOT4 | 2.60e-03 | 1345 | 90 | 11 | EFO_0010736 |
| Disease | epiandrosterone sulfate measurement | 2.64e-03 | 25 | 90 | 2 | EFO_0021120 | |
| Disease | health study participation | 3.04e-03 | 195 | 90 | 4 | EFO_0010130 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QPSPLPRPAPPRRPH | 31 | Q0P6H9 | |
| HPRPFLASPPPALGR | 371 | Q8N350 | |
| SPILPGRHSPAPPPD | 1291 | Q6ZSZ5 | |
| RPTPPQARPSHPGGP | 506 | P46379 | |
| PASPAAPHAPPRALP | 1086 | Q96PE1 | |
| TTRPPPIRPPFSHPI | 306 | P10323 | |
| CPSLGPVPHRPPFEP | 851 | P54259 | |
| PPGTPALPAPAPRSH | 826 | C9J069 | |
| GGPAPRRTAPPPPGH | 36 | Q9NZU7 | |
| PLPCPRHPPFAAAGP | 1111 | Q8TE57 | |
| RPGFLPPLNVSPHPP | 421 | Q69YU3 | |
| LGPAPPPRPPQLERH | 386 | Q6PCT2 | |
| PHSISPRPRPPGRPV | 291 | P36507 | |
| HFRRPPPEHFRRPPP | 746 | Q8IXT5 | |
| APRHSARPGPQPPPT | 496 | Q8IZ40 | |
| GSLPPARLPPFTRPP | 586 | Q2M385 | |
| RRPPEGHPTPRPASP | 1021 | Q8WXD9 | |
| PRFLPRGNAPSPAPP | 201 | Q96DN6 | |
| PGPRHPETSPSFLPP | 221 | A5PL33 | |
| PDGTPPRLPFRAPPA | 81 | Q9Y662 | |
| PPAPPRPRNGYQPHR | 126 | Q7L2J0 | |
| LDPQGPPRRPPPHIL | 836 | Q8N201 | |
| PAESRPFGTLPPRPP | 491 | Q86W92 | |
| PGSPRPPSPPLGLCH | 841 | Q9UKN7 | |
| RHPPTPPEPSGGLPR | 926 | Q9UBS5 | |
| SSDPPAVHPPLPPLR | 821 | O43150 | |
| CPPPPLESGHRSLPP | 236 | Q6VAB6 | |
| RPVLPSVGPPHPPFL | 576 | Q96HB5 | |
| TRARGHLPPGPTPLP | 26 | Q96SQ9 | |
| SPGPHSGAPPVPFRP | 801 | Q9UQ16 | |
| HFRPTPEPPGGPPRR | 486 | O95382 | |
| SRPAPSLPEPHPGPD | 16 | Q9BZM3 | |
| PHALGSRGPPTPAPP | 276 | Q9H1B7 | |
| PSLPALAPSPPHRPD | 956 | O15534 | |
| RDPRLPGPLPPSPAH | 301 | A6NMT0 | |
| PPPPSARHRAHPPQR | 11 | P22001 | |
| PPPPEQIHSAPGPRR | 391 | Q86UU5 | |
| APSPFRAPPFHPPGP | 656 | Q8IZL8 | |
| KPHTPSLPRPPGCPA | 446 | O15265 | |
| PGAPTSFEPRRPPPL | 536 | P58401 | |
| TLAHPVRAPGPGPPP | 711 | O00459 | |
| PGTPPLFSPPPRHHL | 311 | Q9C0K0 | |
| PPPGSPRRSEGHPDP | 156 | Q8N143 | |
| PLPPLHPAVSDPRSP | 1776 | O14647 | |
| PPGRCPAPPHPREST | 136 | A6NHQ4 | |
| PNPLHPRPFPSSRLP | 426 | Q9Y3I1 | |
| GPETPPRPRDQLPPH | 331 | Q99501 | |
| PHSPRRAGPPTPPLF | 181 | B7Z1M9 | |
| RPPPPPPGHKRTLSD | 826 | Q9ULH1 | |
| RTLSDPPSPLPHGPP | 836 | Q9ULH1 | |
| RSPPPPHRPRLPSAE | 286 | O43281 | |
| PLRPPRELHAAPPPA | 36 | Q9NVV2 | |
| SPSPLPGHPPAPARS | 1201 | O60307 | |
| APRRATPPAHPPPRS | 256 | Q5SQI0 | |
| GLRSLYPPPPPPQHL | 1061 | Q13255 | |
| SPPLRHRPRGPPPPS | 851 | Q12770 | |
| HRPRGPPPPSLFGDQ | 856 | Q12770 | |
| APPRPAAPHPRPASR | 11 | A6NKF1 | |
| PRKLPSRPPPHYPGI | 186 | O75923 | |
| PPSPRPAGPTPRGHG | 31 | Q14681 | |
| LPPRPGFFPPPPHSE | 1371 | Q96PC5 | |
| RPHLSPRPPPTGDPG | 1026 | Q9NZ71 | |
| KPSFERGRHGPPPPP | 86 | Q96E39 | |
| PPPPSPGAARPARFS | 141 | H3BV60 | |
| APASPPPPDGPLAHR | 321 | Q2M2I3 | |
| PSLPPHSPRIASPGP | 61 | O15353 | |
| PLDGPRPFPAAPGRH | 1391 | Q6ZNJ1 | |
| SPGPHARSPLPERPP | 241 | Q6ZRT6 | |
| HPGAFPPLPSRPGFP | 651 | Q92540 | |
| PGLRPSHPPRRRPLP | 431 | Q96QH2 | |
| RRPLPPASSLGHPPA | 441 | Q96QH2 | |
| EPGPIRPSHRPGPPV | 1746 | P48634 | |
| PARPPLTPHTFEPRP | 31 | Q96FS4 | |
| PPTPLRGLPPPSSLH | 461 | A6NL88 | |
| FPPRGPQVRGPSHIP | 171 | B1ATL7 | |
| PPTPPRPRDGGTPRH | 476 | Q76KP1 | |
| PGPPPAGPPRAHARL | 106 | Q9Y4C5 | |
| PRAATRPPPLPAHTP | 61 | P28329 | |
| PPHPLPPTGSPRPRQ | 21 | B7Z368 | |
| FRHPNPIPSGLPPFP | 341 | O95628 | |
| APAPPPAPDHLFRPI | 21 | O75312 | |
| PPRLRPFLAAAPGPP | 266 | Q96IQ9 | |
| RPPHRGPPQEPSPSA | 761 | Q8NHH1 | |
| PSTLLRPHNPPGPVP | 511 | Q96MX3 | |
| PPGPHASPVPYRRPR | 21 | Q96MI6 | |
| FPPPRAPGSPRALNP | 666 | Q9BXP2 | |
| RPSSEAPPPGPPHAL | 1876 | Q5T1R4 | |
| PPRPPGPCSFQHFRR | 126 | Q9UQQ2 | |
| PPPPPVGNRPSIHRE | 266 | O43516 | |
| LHPPAPAPSTIPRLP | 691 | Q99835 | |
| IHSPAPPPDPAPRFA | 1006 | O43379 | |
| PPPDPAPRFATSLPH | 1011 | O43379 | |
| PSHIPPPPRHAQRSP | 306 | O95049 | |
| KHSSSAPPPPPPGRR | 171 | Q8TF74 | |
| RLHPGREGPPAPPPV | 216 | Q8TF74 | |
| TVPPPPRGHAPPAAA | 16 | Q8TC26 | |
| PHAPDQPGARRPAPP | 601 | Q6ZVT0 | |
| PPHLVPPQPLPRRGT | 486 | Q9UNY4 | |
| PARLPAPGPRASFPP | 181 | Q9Y5W3 | |
| ALPPPPAGRNHSPLP | 196 | Q13094 | |
| PRPPPRGTPPRRHSF | 26 | Q5TBK1 |